Seqanswers Leaderboard Ad

Collapse

Announcement

Collapse
No announcement yet.
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • Illumina sues Oxford Nanopore

    Hi all,

    Illumina sues Oxford Nanopore...

    http://www.genomeweb.com/sequencing-...t-infringement

    Curious to have your opinion about this....

  • #2
    Looks like ONT has become a threat.
    Illumina used to scoff at them.

    Competition is good for customers. Illumina is a one-trick pony and their technology is headed to the glue factory.

    Comment


    • #3
      Patent fights converge to the more wealthy team as winner.

      Comment


      • #4
        The patents in question as reported by BioIT World
        Discover the latest news in bioinformatics, biomedical research, and drug discovery. Bio-IT World provides topical news coverage and analysis of cutting-edge biotechnologies to deliver individualized medicine.


        Provided herein are Mycobacterium smegmatis porin nanopores, systems that comprise these nanopores, and methods of using and making these nanopores. Such nanopores may be wild-type MspA porins, mutant MspA porins, wild-type MspA paralog porins, wild-type MspA homolog porins, mutant MspA paralog porins, mutant MspA homolog porins, or single-chain Msp porins. Also provided are bacterial strains capable of inducible Msp porin expression.

        Mycobacterium smegmatis nanopores and related methods

        Provided herein are Mycobacterium smegmatis porin nanopores, systems that comprise these nanopores, and methods of using and making these nanopores. Such nanopores may be wild-type MspA porins, mutant MspA porins, wild-type MspA paralog porins, wild-type MspA homolog porins, mutant MspA paralog porins, mutant MspA homolog porins, or single-chain Msp porins. Also provided are bacterial strains capable of inducible Msp porin expression.

        MSP nanopores and related methods

        Comment


        • #5
          Originally posted by SylvainL View Post
          Illumina sues Oxford Nanopore...
          Booo...

          Hopefully the fact that they are not a US company will shield them somewhat.

          Comment


          • #6
            Originally posted by narain View Post
            Patent fights converge to the more wealthy team as winner.
            That's blatantly not true, take the recent IBS V Illumina case as an example.

            Ever heard of David V Goliath?

            Comment


            • #7
              While it is likely that this is Illumina's tactic to stall or distract ONT, WashU being one of plaintiffs does give this claim a little bit of credibility.

              Comment


              • #8
                Originally posted by Brian Bushnell View Post
                Booo...

                Hopefully the fact that they are not a US company will shield them somewhat.
                I thought discrimination was not tolerated on this site!?

                Comment

                Latest Articles

                Collapse

                • seqadmin
                  Techniques and Challenges in Conservation Genomics
                  by seqadmin



                  The field of conservation genomics centers on applying genomics technologies in support of conservation efforts and the preservation of biodiversity. This article features interviews with two researchers who showcase their innovative work and highlight the current state and future of conservation genomics.

                  Avian Conservation
                  Matthew DeSaix, a recent doctoral graduate from Kristen Ruegg’s lab at The University of Colorado, shared that most of his research...
                  03-08-2024, 10:41 AM
                • seqadmin
                  The Impact of AI in Genomic Medicine
                  by seqadmin



                  Artificial intelligence (AI) has evolved from a futuristic vision to a mainstream technology, highlighted by the introduction of tools like OpenAI's ChatGPT and Google's Gemini. In recent years, AI has become increasingly integrated into the field of genomics. This integration has enabled new scientific discoveries while simultaneously raising important ethical questions1. Interviews with two researchers at the center of this intersection provide insightful perspectives into...
                  02-26-2024, 02:07 PM

                ad_right_rmr

                Collapse

                News

                Collapse

                Topics Statistics Last Post
                Started by seqadmin, 03-14-2024, 06:13 AM
                0 responses
                34 views
                0 likes
                Last Post seqadmin  
                Started by seqadmin, 03-08-2024, 08:03 AM
                0 responses
                72 views
                0 likes
                Last Post seqadmin  
                Started by seqadmin, 03-07-2024, 08:13 AM
                0 responses
                81 views
                0 likes
                Last Post seqadmin  
                Started by seqadmin, 03-06-2024, 09:51 AM
                0 responses
                68 views
                0 likes
                Last Post seqadmin  
                Working...
                X